Novo Nordisk tests low-dose Wegovy pill in new weight-loss study
The study reflects growing interest in lower-dose obesity treatments as patients balance weight-loss benefits, costs and potential side effects
19 DE AGO DE 2026Por Administrador FynarkFonte: Bloomberg
The study reflects growing interest in lower-dose obesity treatments as patients balance weight-loss benefits, costs and potential side effects
Fonte original: https://www.bloomberg.com/news/articles/2026-08-19/novo-starts-testing-low-dose-wegovy-pills-in-new-obesity-study
Notícias relacionadas
Global · 26 DE OUT DE 2026
Behind ‘Mad Money’ was a brilliant writer viewers never saw. We lost him too soon
Global · 25 DE OUT DE 2026
Zelenskiy says US fully resumes warnings on ballistic strikes - Reuters
Global · 25 DE OUT DE 2026
More pain may be coming for the AI trade. Why I’m not giving up on it
Global · 25 DE OUT DE 2026